BMY Announces CheckMate -017, -063 Trials Evaluating Opdivo in Previously Treated Squamous NSCLC Show Sustained Survival Benefit
September 07, 2015 at 16:42 PM EDT
Bristol-Myers Squibb Company (NYSE: BMY) today announced longer term survival and safety data from CheckMate ...